Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Synsorb raises C$21 million

Synsorb (TSE:SYB; SYBB) pulled

Read the full 45 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE